$66.06 2.7%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 108 -1.8%
Sentiment 70 0%
Webpage traffic 97,000 -1.6%
Employee Rating 74 0%
Google Adspend $4,718 -46.7%
Google Trends 0%
Linkedin Employees 2,756 N/A
Patents 33 0%
4chan Mentions 0% N/A
Facebook Engagement 18 5.9%
Facebook followers 2,470 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 476 0%
Twitter Followers 2,157 0.1% N/A
Youtube Subscribers 2,610 0%
Instagram Followers 1,509 -0.1%
News Mentions 0%
Reddit Mentions 0%
Business outlook 65 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.

Price $66.06
Target Price Sign up
Market Cap $10.3B
Dividend Yield 0.0049
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23272M217M185M51M75M
Q2 '23298M196M205M75M111M
Q1 '23293M191M202M70M101M
Q4 '22269M181M183M50M88M
Q3 '22278M209M180M90M127M

Insider Transactions

Nusse Roeland filed to sell 51,872 shares at $80.3.
September 1 '23
Kummeth Charles R. filed to sell 1,258,766 shares at $88.4.
July 25 '23
Kummeth Charles R. filed to sell 1,112,817 shares at $83.
June 9 '23
Furlow Brenda S. filed to sell 26,092 shares at $82.1.
December 9 '22
HIGGINS JOHN L filed to sell 5,502 shares at $380.7.
August 12 '22
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.